Salman Otoukesh is a Hematology physician affiliated with City of Hope. OpenAlex indexes 121 publications with 509 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E. Duarte Road
Duarte, CA 91010
Telephone
626-256-4673Registry record last updated 17 Jun 2019.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20251 payment
- ABBVIE INC.Program year20251 payment
- Azurity Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
50.3%Kinase inhibitor28.7%Jakafi73%Imatinib Mesylate27%Part D<11 patientsAntimetabolite9.4%Hydroxyurea100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
18.8%Serotonin-3 Receptor Antagonist9.9%Ondansetron Hcl100%Part D<11 patientsProton pump inhibitor8.8%Pantoprazole Sodium100%Part D<11 patientsAnti-infectives
17.1%Short-acting sulfonamides9.4%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsAzole Antifungal7.7%Posaconazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience
Bone Marrow Transplantation
2025 - Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease
Expert Opinion on Investigational Drugs
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Hope Rugo, MD
City of Hope
James Ito, MD
City of Hope
Victoria Seewaldt
City of Hope
Dean Lim, MD
City of Hope
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”